Document:

Prepared by R.R. Donnelley Financial -- Third Addendum to Lease with Gee-Aspora LLC

 Exhibit 10.91 
  
 THIRD
ADDENDUM TO LEASE 
  
 THIS THIRD ADDENDUM TO LEASE (“Third Addendum”) is made and entered into as of this 31st
day of October, 2001, by and between GEE ASPORA LLC, a California limited liability company (“Landlord”), and CALYPTE BIOMEDICAL CORPORATION, a Delaware corporation (“Tenant”). 
  
 RECITALS 
  
 A.  Landlord’s predecessors-in-interest, Commercial Center Bank, a California corporation (“Commercial”) and Tech Center Partners, a California general partnership (“Tech Center”), and Tenant entered into
an Agreement to Lease dated July 22, 1992, that certain First Addendum to Lease dated September 20, 1992 and that certain Second Addendum to Lease dated July 21, 1997 (collectively, the “Lease”) covering those certain premises consisting
of approximately Twenty Thousand Three Hundred Eleven (20,311) rentable square feet in that certain building situated in the City of Alameda, County of Alameda, State of California, and more commonly known as a 1265 Harbor Bay Parkway (the
“Premises”). 
  
 B.  Landlord acquired fee title to certain real property and title to improvements, including
the Premises, from Tech Center and succeeded to the interest of Tech Center and Commercial under the Lease. 
  
 C.  Landlord and Tenant now desire to amend the Lease according to the terms and conditions set forth herein. Capitalized terms used in this Addendum and not otherwise defined shall have the meaning ascribed to them in the Lease.

  
 AGREEMENT 
  
 NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  
 1.    Condition Precedent To Lease Addendum.    This Amendment and the parties’ obligations hereunder are subject to the receipt by Landlord, no later than fifteen
(15) business days after the date hereof, of the Lender’s Consent, as hereinafter defined. Landlord hereby agrees to use diligent efforts to obtain the Lender’s Consent by such date; however, if Landlord does not receive the Lender’s
Consent by such date, this Amendment shall, at Landlord’s option, thereupon be null and void and of no further force or effect and, in such case, neither party shall have any further rights, obligations, or liabilities hereunder. As used
herein, the term “Lender’s Consent” means either (i) a written consent to this Amendment in a form reasonably satisfactory to Landlord, executed by the holder of the promissory note secured by that certain Deed of Trust (the
“Deed of Trust”) encumbering the fee interest in the real property of which the Premises are a part) recorded on April 27, 1999 in the Official Records of Alameda County, California at Series No. 99166785 (the “Lender”) or (ii)
Lender’s deemed approval of this Addendum pursuant to the terms and conditions of the Deed of Trust. 
  
 2.    Temporary Partial Rental Deferral.    As an accommodation to Tenant and in consideration of the delivery of the L-C and Shares, each as defined herein, Landlord hereby agrees that,
notwithstanding anything to the contrary contained in the Lease but subject to the terms and conditions of this Third Addendum, Landlord shall partially defer the payment of Rent (the “Deferral”) in the amount of Ten Thousand Nine Hundred
Eighty Five Dollars ($10,985.00) per month (the “Deferred Amount”) for each of the months of October, November and December, 2001 and the month of January 2002 (collectively, the “Deferral Period”). As a result of the Deferral,
Tenant agrees to pay Landlord, on or before the fifteenth (15th) day of each month during the Deferral Period, Twenty Thousand Dollars ($20,000.00) as Base Monthly Rent (the “Accommodation Rent”) and One Thousand Dollars ($1,000.00) per
month as a credit towards the Additional Rent payable under the Lease (the “Additional
 

 
Rent Credit”). In the event the Additional Rent Credit exceeds the actual Additional Rent payable under the Lease, such excess amount shall be retained by Landlord as an additional cash
security deposit (the “Additional Cash Security Deposit”) to be held in accordance with the terms and conditions of Section 6 of the Lease. Provided that Tenant is not in default under the Lease and Landlord is not otherwise entitled to
retain or apply the Additional Cash Security Deposit in whole or in part, Landlord shall return the Additional Cash Security Deposit to Tenant upon full repayment of the Deferred Amount as provided herein. In the event the Accommodation Rent and/or
the Additional Rent Credit is not paid on or before the fifteenth (15th) day of each month of the Deferral Period, Tenant shall be in material default under the Lease and shall pay Landlord the late payment charges set forth in Section 5 of the
Lease in addition to all amounts, relief or remedies to which Landlord may otherwise be entitled. Beginning February 1, 2002, Tenant shall repay, together with each installment of Base Monthly Rent, the Deferred Amount for each month of the Deferral
Period according to the following schedule: 
  
 
	 
	 February 1, 2002
 	  	 $10,985less the fair market value of 10,000 shares issued to Landlord pursuant to Section 4 determined by taking the average closing price (the
“Closing Price”) of such shares on the 12th, 15th and 16th of October, 2001; provided, however, that the Closing Price shall be capped at One Dollar ($1.00) per share regardless of the actual Closing Price. If at least 10,000 shares have
not been issued as of February 1, 2002 or such shares are not listed on the OTC, then such Shares shall be valued at Zero Dollars ($0.00).
 
	 
	 March 1, 2002
 	  	 $10,985less the fair market value of 10,000 shares issued to Landlord determined by taking the Closing Price of the shares on the 14th, 15th and 16th
of November, 2001; provided, however, that the Closing Price shall be capped at One Dollar ($1.00) per share regardless of the actual Closing Price. If at least 20,000 shares have not been issued by March 1, 2002 or such shares are not listed on the
OTC, then such Shares shall be valued at Zero Dollars ($0.00).
 

 
 
	 
	 April 1, 2002
 	  	 $10,985less the fair market value of 10,000 shares issued to Landlord determined by taking the Closing Price of the Shares on the 14th, 17th and 18th
of December, 2001; provided, however, that the Closing Price shall be capped at One Dollar ($1.00) per share regardless of the actual Closing Price. If at least 30,0000 shares have not been issued by April 1, 2002 or such shares are not listed on
the OTC, then such Shares shall be valued at Zero Dollars ($0.00).
 
	 
	 May 1, 2002
 	  	 $10,985less the fair market value of the 10,000 shares issued to Landlord determined by taking the Closing Price of the Shares on the 14th, 15th and
16th of January, 2002; provided, however, that the Closing Price shall be capped at One Dollar ($1.00) per share regardless of the actual Closing Price. If at least 40,000 shares have not been issued by May 1, 2002 or such shares are not listed on
the OTC, then such Shares shall be valued at Zero Dollars ($0.00).
 

 
  
 Tenant acknowledges that Landlord is agreeing to the terms and conditions of this
Section 2 as a temporary accommodation to Tenant and nothing contained herein shall be deemed a waiver or reduction of Rent or the waiver or release of any right or remedy of Landlord under the Lease or that is otherwise available to Landlord at
law, in equity, or by statute. Tenant further acknowledges and agrees that Tenant shall resume paying the full Base Monthly Rent and Additional Rent, as set forth in and accordance with the Lease, on February 1, 2002. 
  
 3.    Letter of Credit.    Within five (5) business days of Tenant’s execution of this Addendum,
Tenant shall deliver to Landlord an unconditional, “clean,” irrevocable letter of credit (the “L-C”) in the initial amount of Fifty Thousand Dollars ($50,000.00), which L-C shall be issued by a money-center bank (a bank which
accepts deposits, maintains accounts, has a local San Francisco-Bay Area office which will negotiate a letter of credit,
 
 

 2 

 
and whose deposits are insured by the FDIC) reasonably acceptable to Landlord. The L-C shall be in a form reasonably satisfactory to Landlord and provide, among other things, that (i) Gee-Aspora
LLC, a California limited liability company is the named beneficiary of the L-C, (ii) partial draws under the L-C are permitted, (iii) the L-C is transferable in its entirety without charge to the beneficiary, and (iv) notwithstanding any expiration
date of the L-C, the term of the L-C shall automatically renew throughout the Lease Term and for sixty (60) days following the expiration of the Lease Term for successive, additional one (1) year periods unless, at least thirty (30) days prior to
any such date of expiration, the issuer notifies Landlord in writing that the L-C will not be renewed. Tenant shall pay all expenses, points and/or fees incurred by Tenant in obtaining the L-C. The L-C shall be held by Landlord as security for the
faithful performance by Tenant of all the terms, covenants, and conditions of the Lease, as amended hereby, to be kept and performed by Tenant. The L-C shall not be mortgaged, assigned or encumbered in any manner whatsoever by Tenant without the
prior written consent of Landlord which consent may be withheld in Landlord’s sole and absolute discretion. If Tenant defaults with respect to any provision of the Lease, including, but not limited to the provisions relating to the payment of
Rent, or if Tenant fails to deliver or renew the L-C for at lease an additional one (1) year period at least thirty (30) days before its expiration, Landlord may, but shall not be required to, draw upon all or any portion of the L-C: (a) for payment
of any Rent or any other sum in default, (b) for the payment of any amount that Landlord may reasonably spend or may become obligated to spend by reason of Tenant’s default, (c) to compensate Landlord for any other loss or damage that Landlord
may suffer by reason of Tenant’s default or (d) to apply the proceeds as set forth in items (a) through (c), and cause the remainder to become an “L-C Security Deposit,” as defined below. The use, application or retention of the L-C,
shall not operate as a limitation on any recovery to which Landlord may otherwise be entitled. Any amount of the L-C which is drawn upon by Landlord, but is not used or applied by Landlord, shall be held by Landlord and deemed a security deposit
(the “L-C Security Deposit”). If any portion of the L-C is drawn upon, Tenant shall, within five (5) days after written demand therefor, either (i) deposit cash with Landlord (which cash shall be applied by Landlord to the L-C Security
Deposit) in an amount sufficient to cause the sum of the L-C Security Deposit and the amount of the remaining L-C to be equivalent to the amount of the L-C then required under this Lease or (ii) reinstate the L-C to the amount then required under
this Lease, and if any portion of the L-C Security Deposit is used or applied, Tenant shall, within five (5) days after written demand therefor, deposit cash with Landlord (which cash shall be applied by Landlord to the L-C Security Deposit) in an
amount sufficient to restore the L-C Security Deposit to the amount then required under this Lease, and Tenant’s failure to do so shall be a material default under the Lease. Tenant acknowledges that Landlord has the right to transfer or
mortgage its interest in the Project, in the Building and in this Lease and Tenant agrees that in the event of any such transfer or mortgage its interest in the Project, in the Building and in this Lease, Landlord shall have the right to transfer or
assign the L-C Security Deposit and/or the L-C to the transferee or mortgagee, and in the event of such transfer, Tenant shall look solely to such transferee or mortgagee for the return of the L-C Security Deposit and/or the L-C. Tenant shall,
within five (5) days of request by Landlord, execute such further instruments or assurances as Landlord may reasonably deem necessary to evidence or confirm Landlord’s transfer or assignment of the L-C Security Deposit and/or the L-C to such
transferee or mortgagee. If Tenant shall fully and faithfully perform every provision of this Lease to be performed by it, the L-C Security Deposit and/or the L-C, or any balance thereof, shall be returned to Tenant within thirty (30) days following
the expiration of the Lease Term. 
  
 4.    Stock Issuance.    As additional
consideration to Landlord for the Deferral, Tenant shall issue Landlord Forty Thousand (40,000) shares of Tenant’s Common Stock (the “Shares”). Tenant shall use its best commercially reasonable diligent efforts to issue the Shares to
Landlord as soon as possible but, in no event, later than May 15, 2002. Irrespective of Tenant’s compliance with the terms and conditions of Section 2 above, in the event Tenant fails to deliver the Shares to Landlord on or before May 15, 2002
or fails to use its best commercially reasonable diligent efforts to ensure the Shares are properly registered with the appropriate governmental entities including, but not limited to, the Securities & Exchange Commission in accordance with all
applicable laws, Tenant shall be deemed in material default of the Lease and Landlord may, but shall not be obligated to, draw against the L-C an amount equal to the greater of (i) Forty Three Thousand Nine Hundred Forty Dollars ($43,940.00)
or (ii) the fair market value of the Shares as of May 15, 2002. Tenant represents, warrants and covenants to Landlord that: (i) Tenant is a corporation duly organized, validly existing and in good
 
 

 3 

 
standing under the laws of the State of Delaware and has the corporate power to issue the Shares, (ii) upon issuance of the Shares to Landlord, Tenant has (or will have) a sufficient number of
authorized but unissued shares of common stock to be able to issue all of the Shares, (ii) the Shares, when issued pursuant to the terms of this Addendum, shall be duly authorized, validly issued and outstanding, fully paid, non-assessable and
listed for trading on the NASD over-the-counter exchange (the “OTC”) or other nationally recognized exchange, without any transfer or other restrictions, (iii) the execution and delivery of this Addendum and the consummation of the
transactions provided in this Section 4 do not and will not, with or without the giving of notice, the lapse of time or both, result in the breach of any of the terms and provision of, or constitute a default under, or conflict with, or cause any
acceleration of any obligation of Tenant under, any agreement, indenture or other instrument by which Tenant is bound, Tenant’s Certificate of Incorporation or Bylaws, any judgment, decree, order or award of any court, governmental body, or
arbitrator, or any applicable law, rule or regulation, and (iv) neither Tenant’s report on Form 10-K for the year ended December 31, 2000 nor any other document filed by Tenant with the Securities and Exchange Commission since December 31,
2000, contained a misstatement of a material fact or failed to state a material fact required to be stated therein or necessary to make statements therein not misleading as of the date such filing was made. All representations and warranties made in
this Section 4 shall continue to be true and correct at and as of the issuance and delivery of the Shares to Landlord as if made at the time of such issuance. Notwithstanding anything to the contrary contained herein, in the event this Lease
terminates for any reason before Tenant’s issuance of the Shares to Landlord, Landlord shall be entitled to all of the Shares and Tenant shall, immediately upon demand and compliance with all federal and state securities laws, deliver the
Shares to Landlord. Tenant’s obligation to so deliver the Shares shall survive the termination of the Lease. 
  
 5.    Estoppel.    Tenant agrees that (i) Landlord has performed all of its obligations under the Lease as of the date hereof, and (ii) no event has occurred or is occurring which, with the
passage of time or the giving of notice, or both, would constitute a default by Landlord or Tenant under the Lease. 
  
 6.    Ratification.    The Lease, as amended by this Third Addendum, is hereby ratified by Landlord and Tenant and Landlord and Tenant hereby agree that the Lease, as so amended, shall continue
in full force and effect. In the event of any conflict between this Third Addendum and the Lease, the terms and conditions of this Third Addendum shall control. 
  
 7.    General Provisions. 
  
 (a)  Attorneys’ Fees.    In the event of any action by Landlord or Tenant concerning the subject matter of this Addendum, the prevailing party shall be entitled to recover from the non-prevailing
party its costs and expenses of enforcing or protecting its rights hereunder, including reasonable attorneys’ fees and court costs. 
  
 (b)  Binding on Successors.    The terms and conditions of this Third Addendum shall be binding upon and inure to the benefit of the successors and assignees of the parties.

  
 (c)  Amendments.    No subsequent change or addition to this Third
Addendum shall be binding unless in writing and duly executed by both Landlord and Tenant. 
  
 (d)  Counterparts.    This Third Addendum may be executed in counterparts, each of which shall be an original, but all of which shall constitute one and the same agreement. The parties agree that a
singed copy of this Addendum transmitted by one party to the other party by facsimile transmission shall be binding upon the sending party to the same extent as if it had delivered a signed ink original of this Addendum. 
  
 (e)  Authority.    The undersigned persons represent that they are authorized and have the legal
capacity to enter into this Third Addendum. 
  
 [Signatures On Following Page] 
 

 4 

  
 IN WITNESS WHEREOF, the parties have executed this Third Addendum effective as of the
date first set forth above. 
  
 
	 LANDLORD:
 	 	 TENANT:
 
	 
	 GEE-ASPORA LLC, a California limited liability company
  
 /s/    GLORIA GEE
 By:                                      
       
  
 Co-Manager
 Its:                                      
        
  
 October 31,
 Date:                                      
, 2001
 

 

 

 

 

 

 	 	 CALYPTE BIOMEDICAL CORPORATION, a Delaware corporation
  
 /s/    NANCY E. KATZ
 By:                                      
       
  
 President, CEO, CFO
 Its:                                      
        
  
 October 31,
 Date:                                      
, 2001
  
 By:                                      
       
  
 Its:                                      
        
  
 Date:                                      
, 2001
 

 
 

 5Prepared by R.R. Donnelley Financial -- Form of Common Stock Purchase Agmt Dated 11/13/01

  
 EXHIBIT 10.109 
  
 CALYPTE BIOMEDICAL CORPORATION 
  
 COMMON STOCK 
  
 PURCHASE AGREEMENT 
  
 November 13, 2001

  
 COMMON STOCK 
  
 PURCHASE AGREEMENT 
  
 This Agreement (“Agreement”) is made as of November 13,
2001 (the “Execution Date”), by and among Calypte Biomedical Corporation, a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of
Purchasers attached as Exhibit A hereto. Such persons and entities are hereinafter collectively referred to herein as “Purchasers” and each individually as a “Purchaser.” 
  
 AGREEMENT 
  
 In consideration of the mutual covenants contained in
this Agreement, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company and each Purchaser (severally and not jointly) hereby agree as follows: 
  

Section 1. Authorization of Sale of the Securities 
  
 Subject to the terms and
conditions of this Agreement, the Company has, or before the Closing (as defined below) will have, authorized the sale and issuance of up to $500,000 worth of shares of its Common Stock (the “Common Stock”), priced as set forth in Section
2.1 herein. The shares of Common Stock sold hereunder shall be referred to herein as the “Shares” or the “Securities.” 
  
 Section 2.
Agreement to Sell and Purchase the Securities 
  
 2.1     Sale of Shares.    At
the Closing (as defined in Section 3), the Company will sell to each Purchaser, and each Purchaser will purchase from the Company, at a per share purchase price calculated as 80% of the average closing sale price per Share for the five trading days
immediately preceding the Closing (in other words, the five trading days beginning on November 13, 2001), which price is $            . The number of Shares purchased is set forth next to
such Purchaser’s name on the Schedule of Purchasers attached hereto as Exhibit A (the “Schedule of Purchasers”). 
  
 2.2     Separate Agreement    Each Purchaser shall severally, and not jointly, be liable for only the purchase of the Shares that appear on Exhibit A hereto and that relate to such Purchaser.
The Company’s agreement with each of the Purchasers is a separate agreement, and the sale of Shares to each of the Purchasers is a separate sale. The obligations of each Purchaser hereunder are expressly not conditioned on the purchase by any
or all of the other Purchasers of the Shares such other Purchasers have agreed to purchase. 
  
 Section 3. Closing and Delivery 

 
 3.1    Closing    The Closing of the purchase and sale of the Shares pursuant to this
Agreement (the “Closing”) shall be held on November 20, 2001, at the offices of Heller Ehrman White & McAuliffe, 275 Middlefield Road, Menlo Park, California 94025, or on such other date and place as may be agreed to by the
Company and the Purchasers. 
  
 At or prior to the Closing, each Purchaser shall execute any related agreements or other
documents required to be executed hereunder, dated as of the date of the Closing (the “Closing Date”). 
  
 3.2    Delivery of the Shares at the Closing.    At the Closing, the Company shall deliver to each Purchaser stock certificates registered in the name of such Purchaser, or in such nominee
name(s) as designated by such Purchaser, representing the number of shares of Common Stock to be purchased by such Purchaser at the Closing
 
 

 2 

 
as set forth in the Schedule of Purchasers against payment of the purchase price for such shares. The name(s) in which the stock certificates are to be issued to each Purchaser are set
forth in the Stock Certificate Questionnaire in the form attached hereto as Appendix I, as completed by each Purchaser. 
  
 Section 4.
Representations, Warranties and Covenants of the Company 
  
 Except as set forth on the Schedule of Exceptions attached hereto
as Exhibit B, the Company hereby represents and warrants as of the date hereof to, and covenants with, the Purchasers as follows: 
  
 4.1    Organization and Standing    The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of Delaware, has full corporate power and
authority to own or lease its properties and conduct its business as presently conducted, and is duly qualified as a foreign corporation and in good standing in all jurisdictions in which the character of the property owned or leased or the nature
of the business transacted by it makes qualification necessary (except where the failure to be so qualified would not have a material adverse effect on the business, properties, financial condition or results or operations of the Company). The
Company has no subsidiaries or equity interest in any other entity. 
  
 4.2    Corporate Power;
Authorization    The Company has all requisite corporate power, and has taken all requisite corporate action, to execute and deliver this Agreement, sell and issue the Shares and carry out and perform all of its obligations
under this Agreement. This Agreement constitutes the legal, valid and binding obligation of the Company, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws
relating to or affecting the enforcement of creditors’ rights generally, (ii) as limited by equitable principles generally, including any specific performance, and (iii) as to those provisions of Section 9.3 relating to indemnity or
contribution. The execution and delivery of this Agreement does not, and the performance of this Agreement and the compliance with the provisions hereof and the issuance, sale and delivery of the Shares by the Company will not conflict with, or
result in a breach or violation of the terms, conditions or provisions of, or constitute a default under, or result in the creation or imposition of any lien pursuant to the terms of, the Certificate of Incorporation or Bylaws of the Company or any
statute, law, rule applicable to the Company or regulation or any state or federal order, judgment or decree applicable to the Company or any indenture, mortgage, lease or other agreement or instrument to which the Company or any of its properties
is subject, where such conflict, breach or violation would have a material adverse effect on the Company. 
  
 4.3    Issuance and Delivery of the Shares.    The Shares, when issued and paid for in compliance with the provisions of this Agreement, will be validly issued, fully paid and nonassessable.
The issuance and delivery of the Shares is not subject to preemptive, co-sale, right of first refusal or any other similar rights of the shareholders of the Company or any liens or encumbrances. Such issuance and delivery will not cause neither an
increase in the number of shares issuable pursuant to any securities of the Company that are outstanding as of the Execution Date nor a decrease in the exercise or conversion price, of any such securities. 
  
 4.4    SEC Documents; Financial Statements.    The Company has filed in a timely manner all documents
that the Company was required to file with the Securities and Exchange Commission (the “SEC”) under Sections 13, 14(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the twelve (12)
months preceding the date of this Agreement. The Company has also filed with the SEC registration statements on Forms S-2 and S-8 and, as required by the Securities Act of 1933, as amended, amendments and supplements to such registration statements
(the “Securities Act”). As of their respective filing dates (or, if amended prior to the date of this Agreement, when amended), all documents filed by the Company with the SEC (the “SEC Documents”) complied in all material
respects with the requirements of the Exchange Act. None of the SEC Documents as of their respective dates contained any untrue statement of material fact or omitted to state a material fact required to be stated therein or necessary to make the
statements made therein, in light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Documents (the “Financial Statements”) comply as to form in all material
respects with
 
 

 3 

 
applicable accounting requirements and with the published rules and regulations of the SEC with respect thereto. The Financial Statements have been prepared in accordance with
generally accepted accounting principles consistently applied and fairly present the financial position of the Company at the dates thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of
unaudited statements, to normal, recurring adjustments). 
  
 4.5    Intellectual
Property.    Company owns or possesses adequate rights to use all material patents, patent rights, inventions, trade secrets and know-how described or referred to in the SEC Documents as owned or used by it or that are
necessary for the conduct of its business as presently conducted and as described in the SEC Documents. Except as set forth in the SEC Documents, the Company has not received any notice of, nor has any knowledge of, any infringement of or conflict
with asserted rights of others with respect to any patent, patent right, invention, trade secret or know-how that, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a material adverse effect
on the business, properties, financial condition or results or operations of the Company. 
  
 4.6    Capitalization.    All of the Company’s outstanding shares of capital stock have been duly authorized and validly issued and are fully paid and nonassessable, have been issued in
compliance with all federal and state securities laws, and were not issued in violation of or subject to any preemptive right or other rights to subscribe for or purchase securities. The actual authorized and outstanding capital stock of the Company
as of the date hereof is as set forth in Exhibit B. Except as set forth in Exhibit B, there are no outstanding options to purchase, or any preemptive rights or other rights to subscribe for or to purchase, any securities or obligations convertible
into, or any contracts or commitments to issue or sell shares of the company’s capital stock or any such options, rights, convertible securities or obligations. 
  
 4.7    Litigation.    There is no pending or, to the Company’s knowledge, threatened, action, suit or other proceeding to which the
Company is a party or to which its property or assets are subject. 
  
 4.8    Governmental
Consents.    No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state, or local governmental authority on the part of the Company is required
in connection with the consummation of the transactions contemplated by this Agreement except for (a) compliance with the securities and blue sky laws in the states and other jurisdictions in which shares of Common Stock are offered and/or sold,
which compliance will be effected in accordance with such laws, and (b) the filing of a Form D and all amendments thereto with the SEC. 
  
 4.9    No Material Adverse Change.    Since September 30, 2001, there have not been any changes in the assets, liabilities, financial condition or operations of the
Company from that reflected in the Financial Statements except changes which have not been, either individually or in the aggregate, materially adverse. 
  
 4.10    Listing.    The Company’s Common Stock is traded on the Over the Counter Bulletin Board. 
  

Section 5. Representations, Warranties and Covenants of the Purchasers. 
  
 5.1    Representations and Warranties.    Each Purchaser, severally and not jointly, represents and warrants to and covenants with the Company that: 
  
 (a)  Purchaser, taking into account the personnel and resources it can practically bring to bear on the purchase of the
Securities contemplated hereby, either alone or together with the advice of such Purchaser’s purchaser representative, is knowledgeable, sophisticated and experienced in making, and is qualified to make, decisions with respect to investments in
shares presenting an investment decision like that involved in the purchase of the Securities, including investments in securities issued by the Company, and has requested, received, reviewed and considered, either alone or with such
Purchaser’s purchaser representative, all information Purchaser deems relevant (including the SEC documents) in making an informed decision to purchase the Securities. 
 

 4 

 (b)  Purchaser is acquiring the Securities being acquired by Purchaser pursuant to this Agreement in the
ordinary course of its business and for its own account for investment only and with no present intention of distributing any of such Securities or any arrangement or understanding with any other persons regarding the distribution of such
Securities, except in compliance with Section 5.1(c). 
  
 (c)  Purchaser will not, directly or
indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to buy, purchase or otherwise acquire or take a pledge of) any of the securities purchased hereunder except in compliance with the Securities Act, applicable
blue sky laws, and the rules and regulations promulgated thereunder. 
  
 (d)  Purchaser has
completed or caused to be completed the Stock Certificate Questionnaire, attached hereto as Appendix I, for use in preparation of the Form D to be filed by the Company, and the answers thereto are true and correct as of the date hereof and will be
true and correct as of the filing date of the applicable Form D (provided that Purchaser shall be entitled to update such information by providing notice thereof to the Company prior to the filing date of such Form D). 

 
 (e)  Purchaser has, in connection with its decision to purchase the Securities, relied with respect to the
Company and its affairs solely upon the SEC Documents, the representations and warranties of the Company contained herein and oral statements of the Company’s management made at meetings with the Purchaser. 
  
 (f)  Purchaser is an “accredited investor” within the meaning of Rule 501 of Regulation D promulgated under the
Securities Act or a Qualified Institutional Buyer within the meaning of Rule 144A promulgated under the Securities Act. 
  
 (g)  Purchaser has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby and has taken all necessary action to authorize the execution,
delivery and performance of this Agreement. Upon the execution and delivery of this Agreement by Purchaser, this Agreement shall constitute a valid and binding obligation of Purchaser, enforceable in accordance with its terms, except (i) as limited
by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or affecting the enforcement of creditors’ rights generally, (ii) as limited by equitable principles generally, including any specific performance, and
(iii) as to those provisions of Section 9.3 relating to indemnity or contribution. 
  
 (h)  Awareness of Financial Risk.    Purchaser is fully aware of: (i) the highly speculative nature of the investment in the Shares; (ii) the financial hazards involved; (iii) the lack of liquidity of
the Shares and the restrictions on transferability of the Shares (e.g., that Purchasers may not be able to sell or dispose of the Shares or use them as collateral for loans); and (v) the tax consequences of investment in the Shares. Purchaser
is fully aware of the risk factors set forth in the SEC Documents. 
  
 (i)  No General
Solicitation.    At no time was the Purchaser presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of general advertising or solicitation in connection with the
offer, sale and purchase of the Shares. 
  
 (j)  Compliance with Securities
Laws.    Purchaser understands and acknowledges that, in reliance upon the representations and warranties made by Purchasers herein, the Shares are not being registered with the Securities and Exchange Commission
(“SEC”) nor are they being qualified under the California Corporate Securities Law of 1968, as amended or the laws of any other state, but instead are being issued under an exemption or exemptions from the registration and
qualification requirements of relevant law, which impose certain restrictions on Purchasers’ ability to transfer the Shares. 
  
 (k)  Rule 144.    Purchaser understands that SEC Rule 144 promulgated under the 1933 Act, which permits certain limited sales of unregistered securities requires that the Shares be
held for a minimum period, after they have been purchased and paid for (within the meaning of Rule 144), before they may be resold under Rule 144. Purchaser understands that Rule 144 may indefinitely restrict transfer of the Shares if Purchaser is,
and for so long as Purchaser remains, an “affiliate” of the Company. 
 

 5 

  
 (l)  Legends and Stop-Transfer
Orders.    Purchaser understands that certificates or other instruments representing any of the Shares acquired by Purchaser will bear legends required by federal or state laws which would impose legend obligations on the
Shares as transferred hereby. Purchasers agree that, in order to ensure and enforce compliance with the restrictions imposed by applicable law the Company may issue appropriate “stop transfer” instructions to its transfer agent with
respect to any certificate or other instrument representing the Shares. 
  
 5.2    Restriction on
Short Sales.    Purchaser represents and warrants to and covenants with the Company that Purchaser has not engaged and will not engage in any short sales of the Company’s Common Stock prior to the Closing, except to the
extent that any such short sale is fully covered by shares of Common Stock of the Company other than the Shares. 
  
 5.3    No Advice Provided.    Purchaser understands that nothing in this Agreement or any other materials presented to Purchaser in connection with the purchase and sale of the Shares
constitutes legal, tax or investment advice and that no independent legal counsel has reviewed these documents and materials on Purchaser’s behalf. Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion,
has deemed necessary or appropriate in connection with its purchase of the Shares. 
  
 Section 6. Survival of Representations, Warranties and Agreements.

  
 Notwithstanding any investigation made by any party to this Agreement, all covenants, agreements, representations and
warranties made by the Company and each Purchaser herein and in the certificates for the securities delivered pursuant hereto shall survive the execution of this Agreement, the delivery to the Purchasers of the securities being purchased and the
payment therefor. 
  
 Section 7. Conditions to Company’s Obligations at the Closing 
  
 The Company’s obligation to complete the sale and issuance of the Securities and deliver shares of Common Stock to each Purchaser, individually, as set forth in the Schedule of
Purchasers shall be subject to the following conditions to the extent not waived by the Company: 
  
 7.1    Receipt of Payment.    The Company shall have received payment, by check or wire transfer of immediately available funds, in the full amount of the purchase price for the number of
Shares being purchased by such Purchaser at the Closing as set forth in the Schedule of Purchasers. 
  
 7.2    Representations and Warranties Correct.    The representations and warranties made by such Purchaser in Section 5 hereof shall be true and correct when made, and shall be true and
correct on the Closing Date. 
  
 Section 8. Conditions to Purchasers’ Obligations at the Closing. 
  
 Each Purchaser’s obligation to accept delivery of the Shares and to pay for the Shares shall be subject to the following condition to the extent
not waived by such Purchaser: 
  
 Representations and Warranties Correct.    The
representations and warranties made by the Company in Section 4 hereof shall be true and correct when made, and shall be true and correct on the Closing Date. 
  
 Section 9. Broker’s Fee 
  
 The Company and each Purchaser (severally and not jointly)
hereby represent that there are no brokers or finders entitled to compensation in connection with the sale of the Shares, and shall indemnify each other for any such fees for which they are responsible. 
  
 

 6 

 Section 10. Notices. 
  
 All
notices, requests, consents and other communications hereunder shall be in writing, shall be sent by confirmed facsimile or mailed by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid,
and shall be deemed given when so sent in the case of facsimile transmission, or when so received in the case of mail or courier, and addressed as follows: 
  
 if to the Company, to: 
  
 Calypte Biomedical Corporation 

1265 Harbor Bay Pkwy 
 Alameda, CA 94502 
 Attention: President and Chief Executive Officer 
 Facsimile: (510)
814-8505 
  
 with a copy so mailed to: 
  
 Heller Ehrman White & McAuliffe 
 525 University Avenue Palo

 Alto, California 94301 
 Attention: Bruce W.
Jenett, Esq. 
 Facsimile: (650) 324-0638 
  
 or to such other person at such other place as the Company shall designate to the Purchasers in writing; and 
  
 if to the Purchasers, at the address as set forth at the end of this Agreement, or at such other address or addresses as may have been furnished to the Company in writing. 
  
 Section 11. Miscellaneous. 
  
 11.1    Waivers and Amendments.    Neither this Agreement nor any provision hereof may be changed, waived, discharged, terminated, modified or amended except upon the written consent of the
Company and holders of at least a majority of the Shares. 
  
 11.2    Headings.    The headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be part of this Agreement.

  
 11.3    Severability.    In case any provision contained in this Agreement
should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby. 
  
 11.4    Governing Law.    Except to the extent that the Delaware General Corporation Law shall be
applicable with respect to matters relating to the internal corporate affairs of the Company, this Agreement shall be governed by and construed in accordance with the laws of the State of California applicable to contracts entered into and wholly
performed within the State of California by California residents 
  
 11.5    Counterparts.    This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute but one
instrument, and shall become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties. 
  
 11.6    Successors and Assigns.    Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the
successors, assigns, heirs, executors and administrators of the parties hereto. 
 

 7 

  
 11.7    Entire Agreement.    This Agreement and
other documents delivered pursuant hereto, including the exhibits, constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof and thereof. 
  
 11.8    Payment of Fees and Expenses.    Each of the Company and the Purchasers shall bear its own
expenses and legal fees incurred on its behalf with respect to this Agreement and the transactions contemplated hereby. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be
entitled to reasonable attorney’s fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives as of the day and year first above written. 
  
 
	 CALYPTE BIOMEDICAL CORPORATION
 
	 
	 By:
 	 	                                       
       
 
	  	 	 Name: Nancy E. Katz
 Title:
Chief Executive Officer, President and Chief Financial Officer
 

 
  
 
	 PURCHASER
 
	  

 
 
	 Purchaser
Name:                                  
 
	 By:
 	 	                                       
       
 
	  	 	 Name:                                     
   
 Title:                                     
    
 Address:                                     
 
                                       
       
                                       
       
 Facsimile:                                   
 
 

 
  
  
  
 

 8 

  
 NOTICE TO PURCHASERS IN ALL STATES: 
  
 IN MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY
FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

  
 THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE
PERIOD OF TIME. 
 

 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}]]